PT-141, also known as Bremelanotide, is a synthetic peptide derived from melanocortin receptor agonist research. Unlike compounds that act through vascular pathways, PT-141 has been studied for its interaction with central melanocortin receptors, particularly MC3R and MC4R, which are involved in neurological and behavioral signaling processes.
